# Remifentanil Tapering and Post-adenotonsillectomy Pain in Children

> **NCT03994146** · PHASE4 · TERMINATED · sponsor: **University Hospital, Akershus** · enrollment: 6 (actual)

## Conditions studied

- Child, Only
- Pain
- Tonsillectomy
- Remifentanil

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Sodium Chloride 9mg/mL

## Key facts

- **NCT ID:** NCT03994146
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-16
- **Primary completion:** 2023-08-18
- **Final completion:** 2023-08-18
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Recruitment rate was not compatible with study completion
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03994146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03994146, "Remifentanil Tapering and Post-adenotonsillectomy Pain in Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03994146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*